The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.50
Bid: 40.00
Ask: 43.00
Change: 0.00 (0.00%)
Spread: 3.00 (7.50%)
Open: 41.50
High: 41.50
Low: 41.50
Prev. Close: 41.50
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Scottish Enterprise Awards

9 Feb 2015 07:00

RNS Number : 3432E
Frontier IP Group plc
09 February 2015
 



 

 

AIM: FIPP

 

 

Frontier IP Group Plc

("Frontier IP")

 

Two portfolio companies win awards at Scottish Enterprise Life Sciences Awards 2015

 

Frontier IP, which specialises in the commercialisation of university intellectual property, is pleased to announce that two of its portfolio companies, ex scientia Ltd ("ex scientia"), and Aridhia Informatics Limited ("Aridhia"), each won an award at the prestigious Scottish Enterprise Life Sciences Awards.

 

Professor Andrew Hopkins, the founder and CEO of ex scientia secured the Life Sciences Entrepreneurial Business Leadership Award. ex scientia, a spin-out from the University of Dundee, is pioneering medicines tailored to polypharmacology for a wide range of human diseases. The award acknowledged Professor Hopkins's success as founder and chief executive of ex scientia, as well as his wider academic, commercial and fundraising activities.

 

Aridhia was a joint-winner of the Innovative Collaboration award alongside the University of Glasgow, NHS Greater Glasgow & Clyde, and Thermo Fisher Scientific Ltd, with the award recognising their collective contribution towards the modernisation of Glasgow's hospitals.

 

These awards, run by Scottish Enterprise, Scotland's main economic development agency, recognise the success and achievements of Scotland's internationally-renowned life sciences sector.

 

Neil Crabb, Chief Executive of Frontier IP, said:

 

"We are delighted to see the success of our portfolio companies being recognised and to congratulate Professor Andrew Hopkins of ex scientia and Aridhia on their prestigious awards."

 

 

Enquiries

 

Frontier IP Group Plc

T: 0131 240 1251

Neil Crabb, Chief Executive

Company website: www.frontierip.co.uk

 

Cantor Fitzgerald Europe

(Nominated Adviser and Joint Broker)

T: 020 7894 7000

Mark Percy / Catherine Leftley, Corporate Finance

David Banks, Corporate Broking

Peterhouse Corporate Finance Limited (Joint Broker)

T: 020 7469 0935

Lucy Williams

KTZ Communications

T: 020 3178 6378

Katie Tzouliadis / Deborah Walter

 

 

Notes to Editor:

 

Frontier IP Group plc

www.frontierip.co.uk.

Frontier IP specialises in assisting universities, research institutions and companies in the commercialisation and exploitation of their Intellectual Property.

 

Scottish Enterprise

www.facebook.com/scottishenterprise

Scottish Enterprise is Scotland's main economic development agency and aims to deliver a significant, lasting effect for the Scottish economy. Their role is to help identify and exploit the best opportunities for economic growth. They support ambitious Scottish companies to compete within the global marketplace and help build Scotland's globally competitive sectors. They also work with a range of partners in the public and private sectors to attract new investment to Scotland and to help create a world-class business environment.

 

Ex Scientia Limited

www.exscientia.co.uk

Ex Scientia is a spinout company from the University of Dundee. Ex Scientia has been formed to exploit novel informatics and experimental methods to enable new, more effective, ways of conducting drug discovery.

 

Aridhia Informatics Limited

www.aridhia.com

Aridhia is a spinout and joint venture between University of Dundee, NHS Tayside and Sumerian Europe Ltd.

Aridhia applies innovative analytical and data integration techniques to deliver integrated information to improve healthcare. Aridhia provides actionable insight and joined-up information visibility to support improved healthcare outcomes from both an operational management and a clinical perspective.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRASSDFWMFISEEE
Date   Source Headline
7th May 202410:15 amRNSTVG to collaborate with The Pirbright Institute
2nd May 20247:00 amRNSFrontier IP announces stake in DiaGen
17th Apr 20241:59 pmRNSHolding(s) in Company
12th Apr 20247:00 amRNSAppointment of Chief Financial Officer
2nd Apr 202412:44 pmRNSHolding(s) in Company
14th Mar 20247:00 amRNSUnaudited Half Year Results
4th Mar 20241:40 pmRNSHolding(s) in Company
29th Feb 20243:12 pmRNSSale of shares in Exscientia
30th Jan 202411:45 amRNSHolding(s) in Company
22nd Jan 20247:00 amRNSOctopus invest in Alusid as part of equity funding
29th Dec 202312:00 pmRNSTotal Voting Rights
19th Dec 20234:46 pmRNSHolding(s) in Company
15th Dec 20236:12 pmRNSReplacement - Result of AGM and Directorate Change
15th Dec 20232:07 pmRNSResult of AGM and Directorate Change
13th Dec 20237:00 amRNSPortfolio news - The Vaccine Group
11th Dec 20237:00 amRNSHolding(s) in Company
30th Nov 20235:00 pmRNSTotal Voting Rights
30th Nov 20237:00 amRNSExercise of Options & Director/PDMR Shareholdings
28th Nov 20237:00 amRNSBoard Change
21st Nov 20237:00 amRNSPosting of Annual Report and Notice of AGM
9th Nov 20235:27 pmRNSHolding(s) in Company
3rd Nov 20237:05 amRNSGrant of options
1st Nov 20235:48 pmRNSExercise of Options & PDMR Shareholdings & TVR
31st Oct 20237:01 amRNSBoard changes
31st Oct 20237:00 amRNSFinal results for the year ended 30 June 2023
23rd Oct 20237:00 amRNSNew portfolio company Deakin Bio-Hybrid Materials
12th Oct 20232:05 pmRNSHolding(s) in Company
21st Sep 20237:00 amRNSExscientia announces collaboration with Merck
14th Sep 20235:21 pmRNSHolding(s) in Company
14th Sep 20237:00 amRNSExercise of Options & Total Voting Rights
11th Sep 20237:00 amRNSPortfolio news – Pulsiv appoints Chairman and CPO
8th Sep 20237:00 amRNSExercise of Options & Total Voting Rights
10th Aug 20238:45 amRNSPortfolio news – Fieldwork Robotics
24th Jul 20237:00 amRNSPortfolio news – CamGraPhIC loan facility
20th Jul 20235:18 pmRNSHolding(s) in Company
1st Jun 20237:00 amRNSSale of shares in Exscientia
26th May 20236:06 pmRNSHolding(s) in Company
9th May 20237:00 amRNSTopps Tiles launches first Alusid made tile range
21st Apr 20234:00 pmRNSDirectorate Change
20th Apr 20235:26 pmRNSHolding(s) in Company
27th Mar 20235:17 pmRNSHolding(s) in Company
17th Mar 20232:46 pmRNSGrant of options
15th Mar 20237:00 amRNSBoard changes
15th Mar 20237:00 amRNSUnaudited Half Year Results
30th Jan 20237:00 amRNSAlusid in collaboration with Imerys
9th Jan 20237:00 amRNSCelerum appoints David Gladding as CEO
9th Dec 20224:08 pmRNSResult of AGM
7th Dec 20221:25 pmEQSThe Vaccine Group completes two deadly disease vaccination projects
6th Dec 20227:00 amRNSFrontier IP to host Portfolio Demo Day
5th Dec 20227:00 amRNSThe Vaccine Group completes Lassa fever project

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.